Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Gewirtz, AM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 85 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Choi, JK; Hoang, N; Vilardi, AM; Conrad, P; Emerson, SG; Gewirtz, AM
      Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors inhuman CD34(+) hematopoietic cells

      STEM CELLS
    2. Pertussini, E; Ratajczak, J; Majka, M; Vaughn, D; Ratajczak, MZ; Gewirtz, AM
      Investigating the platelet-sparing mechanism of paclitaxel/carboplatin combination chemotherapy

      BLOOD
    3. Majka, M; Janowska-Wieczorek, A; Ratajczak, J; Ehrenman, K; Pietrzkowski, Z; Kowalska, MA; Gewirtz, AM; Emerson, SG; Ratajczak, MZ
      Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner

      BLOOD
    4. Gewirtz, AM
      Nucleic acid therapeutics for the treatment of human leukemia

      ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS
    5. Gewirtz, AM
      Leukemia Society of America workshop abstracts - Antisense molecular therapy

      BLOOD CELLS MOLECULES AND DISEASES
    6. Jen, KY; Gewirtz, AM
      Suppression of gene expression by targeted disruption of messenger RNA: Available options and current strategies

      STEM CELLS
    7. Majka, M; Rataczak, J; Lee, B; Honczarenko, M; Douglas, R; Kowalska, MA; Silberstein, L; Gewirtz, AM; Ratajczak, MZ
      The role of HIV-related chemokine receptors and chemokines in human erythropoiesis in vitro

      STEM CELLS
    8. Gewirtz, AM
      Oligonucleotide therapeutics: A step forward

      JOURNAL OF CLINICAL ONCOLOGY
    9. Gewirtz, AM
      The prospects for antisense therapy

      HOSPITAL PRACTICE
    10. Gewirtz, AM
      Oligonucleotide therapeutics for human leukemia

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    11. Song, WJ; Sullivan, MG; Legare, RD; Hutchings, S; Tan, XL; Kufrin, D; Ratajczak, J; Resende, IC; Haworth, C; Hock, R; Loh, M; Felix, C; Roy, DC; Busque, L; Kurnit, D; Willman, C; Gewirtz, AM; Speck, NA; Bushweller, JH; Li, FP; Gardiner, K; Poncz, M; Maris, JM; Gilliland, DG
      Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

      NATURE GENETICS
    12. Sokol, DL; Gewirtz, AM
      Monitoring antisense oligodeoxynucleotide activity in hematopoietic cells

      METHODS-A COMPANION TO METHODS IN ENZYMOLOGY
    13. Gewirtz, AM
      Myb targeted therapeutics for the treatment of human malignancies

      ONCOGENE
    14. Agarwal, N; Gewirtz, AM
      Oligonucleotide therapeutics for hematologic disorders

      BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION
    15. Zent, CS; Ratajczak, J; Ratajczak, MZ; Anastasi, J; Hoffman, PC; Gewirtz, AM
      Relationship between megakaryocyte mass and serum thrombopoietin levels asrevealed by a case of cyclic amegakaryocytic thrombocytopenic purpura

      BRITISH JOURNAL OF HAEMATOLOGY
    16. Lee, B; Ratajczak, J; Doms, RW; Gewirtz, AM; Ratajczak, MZ
      Coreceptor chemokine receptor expression on human hematopoietic cells: Biological implications for human immunodeficiency virus-type 1 infection

      BLOOD
    17. PARKER RI; SIEGEL RS; RATAJCZAK MZ; GEWIRTZ AM
      DEFICIENT IN-VITRO MEGAKARYOCYTOPOIESIS AND DECREASED IN-VIVO PLATELET TURNOVER IN CHILDREN AND YOUNG-ADULTS WITH CHRONIC THROMBOCYTOPENIA

      Journal of pediatric hematology/oncology
    18. GEWIRTZ AM
      STRATEGIES FOR IMPROVING THE CLINICAL UTILITY OF OLIGONUCLEOTIDE DRUGS

      Naunyn-Schmiedeberg's archives of pharmacology
    19. GEWIRTZ AM
      STRATEGIES FOR IMPROVING THE CLINICAL UTILITY OF OLIGONUCLEOTIDE DRUGS

      Naunyn-Schmiedeberg's archives of pharmacology
    20. Ratajczak, MZ; Ratajczak, J; Machalinski, B; Majka, M; Marlicz, W; Carter, A; Pietrzkowski, Z; Gewirtz, AM
      Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PIGF) in regulating human haemopoietic cell growth

      BRITISH JOURNAL OF HAEMATOLOGY
    21. GEWIRTZ AM; SOKOL DL; RATAJCZAK MZ
      NUCLEIC-ACID THERAPEUTICS - STATE-OF-THE-ART AND FUTURE-PROSPECTS

      Blood
    22. WLODARSKI P; WASIK M; RATAJCZAK MZ; SEVIGNANI C; HOSER G; KAWIAK J; GEWIRTZ AM; CALABRETTA B; SKORSKI T
      ROLE OF P53 IN HEMATOPOIETIC RECOVERY AFTER CYTOTOXIC TREATMENT

      Blood
    23. RATAJCZAK MZ; PERROTTI D; MELOTTI P; POWZANIUK M; CALABRETTA B; ONODERA K; KREGENOW DA; MACHALINSKI B; GEWIRTZ AM
      MYB AND ETS PROTEINS ARE CANDIDATE REGULATORS OF C-KIT EXPRESSION IN HUMAN HEMATOPOIETIC-CELLS

      Blood
    24. RATAJCZAK MZ; RATAJCZAK J; MACHALINSKI B; MICK R; GEWIRTZ AM
      IN-VITRO AND IN-VIVO EVIDENCE THAT EX-VIVO CYTOKINE PRIMING OF DONOR MARROW-CELLS MAY AMELIORATE POSTTRANSPLANT THROMBOCYTOPENIA

      Blood
    25. DIPAOLA RS; KUCZYNSKI WI; ONODERA K; RATAJCZAK MZ; HIJIYA N; MOORE J; GEWIRTZ AM
      EVIDENCE FOR A FUNCTIONAL KIT RECEPTOR IN MELANOMA, BREAST, AND LUNG-CARCINOMA CELLS

      Cancer gene therapy
    26. GEWIRTZ AM
      DEVELOPING OLIGONUCLEOTIDE THERAPEUTICS FOR HUMAN LEUKEMIA

      Anti-cancer drug design
    27. RATAJCZAK MZ; MARLICZ W; RATAJCZAK J; WASIK M; MACHALINSKI B; CARTER A; GEWIRTZ AM
      EFFECT OF HEPATOCYTE GROWTH-FACTOR ON EARLY HUMAN HEMATOPOIETIC-CELL DEVELOPMENT

      British Journal of Haematology
    28. RATAJCZAK MZ; RATAJCZAK J; MARLICZ W; PLETCHER CH; MACHALINSKI B; MOORE J; HUNG HL; GEWIRTZ AM
      RECOMBINANT HUMAN THROMBOPOIETIN (TPO) STIMULATES ERYTHROPOIESIS BY INHIBITING ERYTHROID PROGENITOR-CELL APOPTOSIS

      British Journal of Haematology
    29. RATAJCZAK J; LEE B; GEWIRTZ AM; RATAJCZAK MZ
      IN-VITRO STUDIES ON THE PATHOGENESIS OF AIDS-RELATED ANEMIA

      Blood
    30. MACHALINSKI B; PLUCIENNIK E; SAMUEL AA; FRANCOIS H; CZAJKA R; GEWIRTZ AM; RATAJCZAK MZ
      A CONVENIENT AND ECONOMICAL METHOD FOR LONG-DISTANCE SHIPMENT OF NON-FROZEN HUMAN MONONUCLEAR CORD-BLOOD CELLS

      Blood
    31. SOKOL DL; ZHANG X; GEWIRTZ AM
      DIRECT IN-VIVO DETECTION OF HYBRIDIZATION BETWEEN OLIGODEOXYNUCLEOTIDES AND TARGET MESSENGER-RNA

      Blood
    32. WLODARSKI P; WASIK M; RATAJCZAK MZ; SEVIGNANI C; HOSER G; KAWIAK I; GEWIRTZ AM; CALABRETTA B; SKORSKI T
      ROLE OF P53 IN HEMATOPOIETIC RECOVERY AFTER CYTOSTATIC TREATMENT

      Blood
    33. RATAJCZAK MZ; RATAJCZAK J; MACHALINSKI B; PIETRZKOWSKI Z; SOKOL D; CARTER A; GEWIRTZ AM
      ROLE OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF), PLACENTA DERIVED GROWTH-FACTOR (P1GF) FLT-1/KDR AND FLK-1 RECEPTOR AXES IN HUMAN FETAL AND ADULT HEMATOPOIESIS/

      Blood
    34. GEWIRTZ AM; LUGER S; SOKOL D; GOWDIN B; STADTMAUER E; RECCIO A; RATAJCZAK MZ
      TREATING HUMAN MYELOGENOUS LEUKEMIA WITH C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDES - 2 YEARS CLINICAL-EXPERIENCE

      Journal of investigative medicine
    35. RATAJCZAK MZ; RATAJCZAK J; FORD J; KREGENOW R; MARLICZ W; GEWIRTZ AM
      FLT3 FLK-2 (STK-1) LIGAND DOES NOT STIMULATE HUMAN MEGAKARYOPOIESIS IN-VITRO/

      Stem cells
    36. CALABRETTA B; SKORSKI T; RATAJCZAK MZ; GEWIRTZ AM
      ANTISENSE STRATEGIES IN THE TREATMENT OF LEUKEMIAS

      Seminars in oncology
    37. GEWIRTZ AM; STEIN CA; GLAZER PM
      FACILITATING OLIGONUCLEOTIDE DELIVERY - HELPING ANTISENSE DELIVER ON ITS PROMISE - COMMENTARY

      Proceedings of the National Academy of Sciences of the United Statesof America
    38. GEWIRTZ AM
      PERTURBING GENE-EXPRESSION WITH OLIGODEOXYNUCLEOTIDES - RESEARCH AND POTENTIAL THERAPEUTIC APPLICATIONS

      The Mount Sinai journal of medicine
    39. RATAJCZAK MZ; RATAJCZAK J; SKORSKA M; MARLICZ W; CALABRETTA B; PLETCHER CH; MOORE J; GEWIRTZ AM
      EFFECT OF BASIC (FGF-2) AND ACIDIC (FGF-1) FIBROBLAST GROWTH-FACTORS ON EARLY HEMATOPOIETIC-CELL DEVELOPMENT

      British Journal of Haematology
    40. RATAJCZAK MZ; PLETCHER C; MARLICZ W; WASIK M; MACHALINSKI B; RATAJCZAK J; MOORE J; GEWIRTZ AM
      A RAPID METHOD FOR ISOLATING HUMAN HEMATOPOIETIC STEM-CELLS (HHSC)

      Blood
    41. GEWIRTZ AM; LUGER S; SOKOL D; GOWDIN B; STADTMAUER E; RECCIO A; RATAJCZAK MZ
      OLIGODEOXYNUCLEOTIDE THERAPEUTICS FOR HUMAN MYELOGENOUS LEUKEMIA - INTERIM RESULTS

      Blood
    42. RATAJCZAK MZ; MACHALINSKI B; RATAJCZAK J; SKORSKI T; MARLICZ W; GEWIRTZ AM
      IN-VITRO AND IN-VIVO EVIDENCE THAT EX-VIVO CYTOKINE PRIMING OF TRANSPLANTED MARROW-CELLS MAY AMELIORATE POSTTRANSPLANT THROMBOCYTOPENIA

      Blood
    43. RATAJCZAK MZ; MARLICZ W; RATAJCZAK J; MACHALINSKI B; WASIK M; GEWIRTZ AM
      ROLE OF C-MET RECEPTOR (MET-R) HEPATOCYTE GROWTH-FACTOR (HGF) AXIS INHUMAN HEMATOPOIESIS

      Blood
    44. LUGER SM; RATAJCZAK J; RATAJCZAK MZ; KUCZYNSKI WI; DIPAOLA RS; NGO W; CLEVENGER CV; GEWIRTZ AM
      A FUNCTIONAL-ANALYSIS OF PROTOONCOGENE VAVS ROLE IN ADULT HUMAN HEMATOPOIESIS

      Blood
    45. HIJIYA N; GEWIRTZ AM
      ONCOGENES, PROTOONCOGENES, AND TUMOR-SUPPRESSOR GENES IN ACUTE MYELOGENOUS LEUKEMIA

      Journal of pediatric hematology/oncology
    46. GEWIRTZ AM
      INITIAL CLINICAL-EXPERIENCE TREATING CHRONIC MYELOGENOUS LEUKEMIA (CML) WITH C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDES

      AIDS research and human retroviruses
    47. GEWIRTZ AM
      MEGAKARYOCYTOPOIESIS - THE STATE-OF-THE-ART

      Thrombosis and haemostasis
    48. GEWIRTZ AM; ZHANG J; RATAJCZAK J; RATAJCZAK M; PARK KS; LI CQ; YAN ZQ; PONCZ M
      CHEMOKINE INHIBITION OF IN-VITRO MEGAKARYOCYTOPOIESIS

      Thrombosis and haemostasis
    49. OBRIEN SG; GEWIRTZ AM; RULE SA; HAWKINS TE; RATAJCZAK MZ; SAVAGE D; LUGER SM; GOLDMAN JM
      AUTOGRAFTING FOR CML USING BONE-MARROW PURGED WITH MYB ANTISENSE OLIGONUCLEOTIDE

      Experimental hematology
    50. RATAJCZAK MZ; GEWIRTZ AM
      THE BIOLOGY OF HEMATOPOIETIC STEM-CELLS

      Seminars in oncology
    51. BELTINGER C; SARAGOVI HU; SMITH RM; LESAUTEUR L; SHAH N; DEDIONISIO L; CHRISTENSEN L; RAIBLE A; JARETT L; GEWIRTZ AM
      BINDING, UPTAKE, AND INTRACELLULAR TRAFFICKING OF PHOSPHOROTHIOATE-MODIFIED OLIGODEOXYNUCLEOTIDES

      The Journal of clinical investigation
    52. CLEVENGER CV; NGO W; SOKOL DL; LUGER S; GEWIRTZ AM
      VAV IS NECESSARY FOR PROLACTIN-STIMULATED PROLIFERATION AND IS TRANSLOCATED INTO THE NUCLEUS OF A T-CELL LINE

      The Journal of biological chemistry
    53. GEWIRTZ AM; ZHANG J; RATAJCZAK J; RATAJCZAK M; PARK KS; LI CQ; YAN ZQ; PONCZ M
      CHEMOKINE REGULATION OF HUMAN MEGAKARYOCYTOPOIESIS

      Blood
    54. RATAJCZAK MZ; KUCZYNSKI WI; SOKOL DL; MOORE JS; PLETCHER CH; GEWIRTZ AM
      EXPRESSION AND PHYSIOLOGICAL SIGNIFICANCE OF KIT-LIGAND AND STEM-CELLTYROSINE KINASE-1 RECEPTOR-LIGAND IN NORMAL HUMAN CD34(-KIT(+) MARROW-CELLS(), C)

      Blood
    55. SKORSKI T; KANAKARAJ P; NIEBOROWSKASKORSKA M; RATAJCZAK MZ; WEN SC; ZON G; GEWIRTZ AM; PERUSSIA B; CALABRETTA B
      PHOSPHATIDYLINOSITOL-3 KINASE-ACTIVITY IS REGULATED BY BCR ABL AND ISREQUIRED FOR THE GROWTH OF PHILADELPHIA-CHROMOSOME-POSITIVE CELLS/

      Blood
    56. LUGER SM; RATAJCZAK J; RATAJCZAK MZ; KUCZYNSKIK WI; NGO W; CLEVENGER CV; GEWIRTZ AM
      A FUNCTIONAL-ANALYSIS OF PROTOONCOGENE VAVS ROLE IN ADULT HUMAN HEMATOPOIESIS

      Blood
    57. RATAJCZAK MZ; RATAJCZAK J; MARLICZ W; MOORE J; GEWIRTZ AM
      A KINETIC AND FUNCTIONAL-ANALYSIS OF RECEPTORS WITH INTRINSIC TYROSINE KINASE-ACTIVITY IN NORMAL HUMAN HEMATOPOIETIC PROGENITOR CELLS

      Blood
    58. RATAJCZAK J; RATAJCZAK MZ; GEWIRTZ AM
      EX-VIVO EXPANSION OF HUMAN MEGAKARYOCYTE (MEG) PROGENITOR CELLS (CFU-MEG)

      Blood
    59. ZENT CS; HORNKOHL A; AREPALLY G; RATAJCZAK J; ANASTASI J; GEWIRTZ AM; HOFFMAN PC
      CYCLIC THROMBOCYTOPENIA - THROMBOPOIETIN RESPONSE TO SPONTANEOUS CHANGES IN PLATELET COUNTS

      Blood
    60. RATAJCZAK MZ; RATAJCZAK J; MARLICZ W; FORD J; KREGENOW R; GEWIRTZ AM
      STEM-CELL TYROSINE KINASE-1 LIGAND (STK-1L) DOES NOT STIMULATE HUMAN MEGAKARYOCYTOPOIESIS IN-VITRO

      Blood
    61. RATAJCZAK MZ; RATAJCZAK J; KREGENOW DA; GEWIRTZ AM
      GROWTH-FACTOR STIMULATION OF CRYOPRESERVED CD34(-MARROW CELLS INTENDED FOR TRANSPLANT - AN IN-VITRO STUDY TO DETERMINE OPTIMAL TIMING OF EXPOSURE TO EARLY ACTING CYTOKINES() BONE)

      Stem cells
    62. GEWIRTZ AM
      OLIGODEOXYNUCLEOTIDE BASED THERAPEUTICS OF HUMAN NEOPLASTIC DISEASES

      AIDS research and human retroviruses
    63. GEWIRTZ AM
      TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA (CML) WITH C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDES

      Bone marrow transplantation
    64. RATAJCZAK MZ; RATAJCZAK J; KREGENOV DA; KUCZYNSKI WI; SKORSKI T; GEWIRTZ AM
      CYTOKINE STIMULATION OF CD34-MARROW CELLS PRIOR TO CRYOPRESERVATION ENHANCES THEIR POSTTHAWING PROLIFERATIVE POTENTIAL( BONE)

      Folia histochemica et cytobiologica
    65. SMALL D; LEVENSTEIN M; KIM E; CAROW C; AMIN S; ROCKWELL P; WITTE L; BURROW C; RATAJCZAK MZ; GEWIRTZ AM; CIVIN CI
      STK-1, THE HUMAN HOMOLOG OF FLK-2 FLT-3, IS SELECTIVELY EXPRESSED IN CD34(+) HUMAN BONE-MARROW CELLS AND IS INVOLVED IN THE PROLIFERATION OF EARLY PROGENITOR STEM-CELLS/

      Proceedings of the National Academy of Sciences of the United Statesof America
    66. HIJIYA N; ZHANG J; RATAJCZAK MZ; KANT JA; DERIEL K; HERLYN M; ZON G; GEWIRTZ AM
      BIOLOGIC AND THERAPEUTIC SIGNIFICANCE OF MYB EXPRESSION IN HUMAN-MELANOMA

      Proceedings of the National Academy of Sciences of the United Statesof America
    67. RATAJCZAK MZ; KUCZYNSKI WI; ONODERA K; MOORE J; RATAJCZAK J; KREGENOW DA; DERIEL K; GEWIRTZ AM
      A REAPPRAISAL OF THE ROLE OF INSULIN-LIKE GROWTH-FACTOR-I IN THE REGULATION OF HUMAN HEMATOPOIESIS

      The Journal of clinical investigation
    68. LUGER SM; RATAJCZAK MZ; STADTMAUER EA; MANGAN P; MAGEE D; SILBERSTEIN L; EDELSTEIN M; NOWELL P; GEWIRTZ AM
      AUTOGRAFTING FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) WITH C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE PURGED BONE-MARROW - A PRELIMINARY-REPORT

      Blood
    69. RATAJCZAK MZ; MITJAVILA MT; RATAJCZAK J; KUCZYNSKI W; KREGENOW D; GEWIRTZ AM
      HUMAN ERYTHROPOIESIS IN A SERUM-FREE CULTURE SYSTEM - A REAPPRAISAL OF THE ROLE OF INSULIN

      Blood
    70. XIONG T; KUCZYNSKI WI; GEWIRTZ AM
      STRATEGIES FOR DETECTING DEVELOPMENTALLY-REGULATED GENES IN NORMAL HUMAN MEGAKARYOCYTES

      Blood
    71. RATAJCZAK MZ; KUCZYNSKI WI; MOORE J; GEWIRTZ AM
      FACS SORTED HUMAN CD34-MARROW CELLS COEXPRESS C-KIT LIGAND (KL) AND STEM-CELL TYROSINE KINASE-1 RECEPTOR-LIGAND (STK-1 L)( BONE)

      Blood
    72. MORROW DM; XIONG N; GETTY RR; RATAJCZAK MZ; MORGAN D; SEPPALA M; RIITTINEN L; GEWIRTZ AM; TYKOCINSKI ML
      HEMATOPOIETIC PLACENTAL PROTEIN-14 - AN IMMUNOSUPPRESSIVE FACTOR IN CELLS OF THE MEGAKARYOCYTIC LINEAGE

      The American journal of pathology
    73. GEWIRTZ AM
      OLIGODEOXYNUCLEOTIDE-BASED THERAPEUTICS FOR HUMAN LEUKEMIAS

      Stem cells
    74. RATAJCZAK MZ; LIGHT BL; RATAJCZAK J; KUCZYNSKI WI; GEWIRTZ AM
      HUMAN ERYTHROPOIESIS IN-VITRO - DEFINITION, AND CLINICAL IMPLICATIONS, OF OPTIMAL STIMULATORY CONDITIONS

      Cancer research, therapy & control
    75. GEWIRTZ AM
      POTENTIAL THERAPEUTIC APPLICATIONS OF ANTISENSE OLIGODEOXYNUCLEOTIDESIN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA

      Leukemia & lymphoma
    76. RATAJCZAK MZ; RATAJCZAK J; KUCZYNSKI W; LIGHT B; LUSK EJ; GEWIRTZ AM
      IN-VITRO SENSITIVITY OF HUMAN HEMATOPOIETIC PROGENITOR CELLS TO 4-HYDROPEROXYCYCLOPHOSPHAMIDE

      Experimental hematology
    77. TAKESHITA K; BOLLEKENS JA; HIJIYA N; RATAJCZAK M; RUDDLE FH; GEWIRTZ AM
      A HOMEOBOX GENE OF THE ANTENNAPEDIA CLASS IS REQUIRED FOR HUMAN ADULTERYTHROPOIESIS

      Proceedings of the National Academy of Sciences of the United Statesof America
    78. MIGLIACCIO AR; MIGLIACCIO G; MANCINI G; RATAJCZAK M; GEWIRTZ AM; ADAMSON JW
      INDUCTION OF THE MURINE W-PHENOTYPE IN LONG-TERM CULTURES OF HUMAN CORD-BLOOD CELLS BY C-KIT ANTISENSE OLIGOMERS

      Journal of cellular physiology
    79. SCHMAIER AH; AMENTA S; XIONG T; HEDA GD; GEWIRTZ AM
      EXPRESSION OF PLATELET C1 INHIBITOR

      Blood
    80. LUGER SM; RATAJCZAK MZ; DIPAOLA R; GEWIRTZ AM
      FUNCTIONAL REQUIREMENT FOR THE VAV PROTOONCOGENE PRODUCT, P95VAV, IN HUMAN HEMATOPOIESIS

      Blood
    81. BELTINGER CP; SMITH RM; SARGOVI HU; GEWIRTZ AM
      UPTAKE MECHANISMS AND INTRACELLULAR TRAFFICKING OF PHOSPHOROTHIOATE MODIFIED OLIGODEOXYNUCLEOTIDES

      Blood
    82. RATAJCZAK MZ; GEWIRTZ AM
      THE HUMAN C-KIT GENE 5'-REGION - SEQUENCE-ANALYSIS AND FUNCTIONAL-CHARACTERIZATION

      Blood
    83. SMALL D; LEVENSTEIN M; KIM E; CAROW CE; AMIN S; RATAJCZAK M; GEWIRTZ AM
      STK-1, A HUMAN HOMOLOG OF FLK-2 FLT3, IS ABERRANTLY EXPRESSED IN HUMAN LEUKEMIAS AND MAY BE INVOLVED IN THE GROWTH AND OR DIFFERENTIATION OF HEMATOPOIETIC STEM PROGENITOR CELLS/

      Blood
    84. KUCZYNSKI WI; RATAJCZAK MZ; GEWIRTZ AM
      STEM-CELL KINASE-1 (STK-1), HUMAN HOMOLOG OF THE MURINE-FLT3 FLK2 TYROSINE KINASE RECEPTOR GENE, IS EXPRESSED ON A WIDE VARIETY OF NONHEMATOPOIETIC TUMOR-CELL TYPES/

      Blood
    85. RATAJCZAK MZ; KUCZYNSKI WI; RATAJCZAK J; LIGHT B; LUGER SM; GEWIRTZ AM
      A SIMPLE, EFFICIENT METHOD FOR CRYOPRESERVING BONE-MARROW CELLS IN A -80-DEGREES-C MECHANICAL FREEZER

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 13/08/20 alle ore 14:58:33